Overall, the researchers found that:
> 32.1% of the study drugs reached the lungs in the overall group of
participants.
> 35.2% of the study drugs reached the lungs in the participants with moderate
COPD.
> 28.7% of the study drugs reached the lungs in the participants with severe or
very severe COPD.
The figure below shows these results.
Average percentage of study drugs
that reached the lungs
100
)%(
sgurd
75
yduts
50
35.2% fo
28.7% egatnecreP
25
0
Participants Participants with
with moderate severe or very
COPD severe COPD
What medical problems happened during the
study?
This section is a summary of the medical problems the participants had
during the study that the study doctors thought might be related to the study
treatment. These medical problems are called “adverse reactions”. An adverse
reaction is considered “serious” when it is life-threatening, causes lasting
problems, or requires hospital care.
6 | Clinical Study Results